MedTrace Logo

The Influence of Adjuvant Medical Treatment of Peritoneal Endometriosis on the Outcome of IVF. A Prospective Randomized Analysis.

NCT01682642 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2015-03-20

Study results available
· View outcomes & findings →

Summary

In this study of endometriosis patients we compare a common treatment of surgical therapy and medical treatment for 3 months (Zoladex) with patients receiving only surgical therapy. In both cases they immediately start In Vitro Fertilization (IVF) treatment.

Conditions

Interventions

DRUG

Zoladex

after surgical vaporization patients are treated with Zoladex for 3 months before starting IVF treatment

Sponsors & Collaborators

  • Onze Lieve Vrouw Hospital

    collaborator OTHER

  • AZ Jan Palfijn Gent

    lead OTHER

Principal Investigators

  • Wim Decleer, gynecologist · Fertility Center AZ Jan Palfijn Gent

  • Paul Devroey, Professor · Fertility Center AZ Jan Palfijn Gent

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
38 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01682642 on ClinicalTrials.gov